Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaWVUUlpkeU1ZY2lCcFdGcHQwbHJCc045LUxka0tlRWZCMElHUEZWR215b0pkaG9xaWxEeERreUhMZU5VTmh4TDM1djk4V1RZYmJ0a3pmeG9rbklqRFF3NW9hbFFzMk9PUU0tYkdqRGluY2pDOWlXRDBWRXpOMjdIWXF1MlAyMnR1QUF3OHJzZjNfYmpqSk45czZGSElfTVgteURveXdWcDNqQlpObjBrTUhweGtBTFJZZHUw?oc=5" target="_blank">Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
GameStop Stock Hits a New 52-Week High: What's Going On?
The Myth of St. Francis
Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League
The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5GTlRIU2xXbjg1QzAxZGRwM2lQZ2U3ekpTS0V3UEhoQXlsUllfSy02YmJhWFRaSW9ldGhtOERCazVmN05EVWM5Q1VZZGdKbnMtWm9YR3RkcmVIRXYxTkc4cDh6anRGRF9X?oc=5" target="_blank">Once-Monthly Abilify Maintena Injection: What You Need to Know</a>&nbsp;&nbsp;<font color="#6f6f6f">GoodRx</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOVXZnOHJEdDNCZFkyOUIxeGtuOFplNEx2WVZYdlRTbTE0U1RKWU1Bc2w5THdSWTltS0FpRUFLN1llSVU3R0tOSUZ2Nk1wcDdFV29zMDZTZlhuMENBem9rZ2lBYzBiNzdXVWVDUzRpRldQMkZKWTNURjhDMEhjWlNfVUtxRWRRbFpKdjBqYzBpb0lwa0E3eVl1SXNNMA?oc=5" target="_blank">FDA Approves Bi-Monthly Aripiprazole Injection for Schizophrenia, Bipolar Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">HCPLive</font>
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE10SkpIa1VRQUgzODZBMlBJYWtoNUFKaUZuejZQNi1Qck1lZ2NZM0pTaW5pb2RKeUJiWGNJek9BQ09veVRDVE1OdUJrMUIxaThuTTVqT3doYmQ?oc=5" target="_blank">Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxNcXYwYXo1SUl3NGRXYmR3QnBmcGZybXFfc2o2UERITkpYMElVNlBKM3JBNzQ2d29UbFpPMXFtelJOZHh5UzhuclFzNGx0Qm1IdGV6NFJSSEgwb2VMNGNKbXlDRjNURHc4dTBTT1lVOXZSTVY0em54M2hfbENGblQ3TzREaVpjQnJScTh5T1d3LUZ0RElKX2pWZFd5aUJXaGZaeXZtZURrcnJUS0dhRlRnLW12cWFpRlhHMzB6dDdoZGtCWXN3d292QW5qV3RnOVpFd1pYV2VUbkNPeUNocG5NUGVJdw?oc=5" target="_blank">FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQY2hXRXc3R01NRWdGa2lGX3ZzUTR5S2ZDaDFIcGpNNjlXa242emVBLW5namZhRVI2LUE0LWNSNVVxSGZ6Skl5RkJSd21NYUFnR1FOOEtRMDBUbmJOUDNoeE8xV0JXaExSWGlxRmNSUE5nQkNxb1FzeEVoY3JvdkxXdkhnQWZaZktBbUdxY3BJdzcwZFptRWVlVnZhcGg1aEpuMFZyczR4Tm1jWUJ6Rmc?oc=5" target="_blank">NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatric Times</font>
<a href="https://news.google.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?oc=5" target="_blank">FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxONi1lcDRyUHhxeHY0a24xazItQjJwem00b2ZmMVpsWUpYTnVUblZhbnd3dmlfeTUzN3hYX0VudkN3RUpZZEhUakt6Rk93d19jU3Mxb1dhRHpwUlA4b0ZnUDFpeXhVT2x3eWJCbFZBZGltNHoyeFRkbloyYzgzZV9RWjlFYmNuczJQZkVnWjdJM2NYdFY1Rko1clhB?oc=5" target="_blank">FDA Accepts NDA for Longer-Acting Aripiprazole</a>&nbsp;&nbsp;<font color="#6f6f6f">Managed Healthcare Executive</font>
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5tbkswZGtXekRLdFozOUZEeDhjSl8zSTZxal9hOThlOTZMZlNWT2NmakRhdVpnSGYxMHlPV1lmUHVQdU9EZjlqQ0VmT3hVam1iX01LQWJ6T012RHljMzE3cHhGQ3ZLZlN4cE9neQ?oc=5" target="_blank">Med Check: Zuranolone for Depression, Uzedy for Schizophrenia, and More</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatry Online</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPSmNta0c1NUNpNTI2MmdES3JnaVBsanR4a1dzQzVTZGlJZ1dRSkduOXB2YzRRVWU1UFV5MTFYTnNrd2JjV01TZjBBNXBvZkVSckI0VFVmVlo0ZlBIQnE1YnYyU1NBRlB3XzNOVlRaVWNxWmxPUTkzQmJOWk9zNUwzQmJSajl0VGcyMHllMVNKUTE0YjBSRUlpQlQxNA?oc=5" target="_blank">Abilify Asimtufii Approved for Schizophrenia, Bipolar I Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Professionals Reference</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQdDZJTHhxTlo1NE50LVVyYnFxMUVlZHBLOXIyU2lDWmVWY2JVVDhqRTY4LUU4eWFBME5ibVNxWDZBVzRscjVDTnNOQng1czlLQTlBNE1taTZPbm5qcmxNZDZjd21FOVFnaUIwTW1XUDZVMHgxcTBvQmxXbnplVUVGM28tUlRqeGlmU1BWUkV1X2RTZnRPX3ZZUHFZOGZDMkhzakNyZUpfUTE?oc=5" target="_blank">FDA Greenlights First Bi-Monthly Injectable for Schizophrenia, Bipolar 1 Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNcUZISWlqM2VQWktqU216UUZWWVM2NWxzd2ZWM3lDZktoV2tpWC1hSUg3ZVVGRUxIcWpVa3dOalRjZUxnSlEyakdNZjVteEJoNDZSdXBkNnFON3owLUp5NmpTRTQwMXNoS2hhRUJWQ2NHSDVUdURnSEZGSFhXMk5tMVJBeUhRZjFQN0JMMHhyMFpJY0dC?oc=5" target="_blank">Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5yaFU2WW1ZajlWaTBGZXRtTEpCVmRMc0xxeXlsNUlHSjFvY0VwanVCRXNJRmtwcEN2aGZWR1FXTWZhMUdUMFJoWVdyZTJVTlBRRENicE9uWl9EVjdReFFB?oc=5" target="_blank">Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQNjZENmctVEw2UlBRVjlNQ3Q4U2twMmt1V1dHOG5adk45RW5iR1hXZHhBSEZ4T2JFb2VQLV9kX1dqdEZ6d3ZteDhJQV9xbzBPR0FVTEt3Zl9iQ2dpVzhERW43TXg3elFvQjhLZUtOOWVLQmtpWjlVU0F1MFVLdWpPRTlCbnlfMVA0dllVMTdsNWpjRnUzam04Vkp0UUYzNnFrTzVQS2tTU1UxSDFxUHB6WjVDZDNrTlFyUGc?oc=5" target="_blank">Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0UkxNNGNOVTNzdTR5amo3ZndNN1NwSUpOeFpUajB2Q0owTHdkN3VQOU8xdlNLM1R0NTd5SnlLNWQyVGZ6MjFsZXJNTzR1VmNZanRmNXZ4MXZDT0N5OVdR?oc=5" target="_blank">Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOblRxUVJsdDVOemp4VTVydnBaMmZJZk5KUElsbUktMlZLM0ZxeW1Jdk42ZkZGSVd2ZFhrN2dHRG1UTm1jRU9Bcmo0enMwR2t4dDFmQjUwOGRMcldIVFo0RmNvQnJrbTFTTUVRNFNtb0EtbTlSbzNnSW9wOGJrcm9IMng1dHJDXzdEUU01N1BvZzJMVXhHd0pRWkpoTjR2VDlyc2huekc5cENzRmt4NFhSRGFldDRmTmpWYUtja2FHQ19aZDg?oc=5" target="_blank">Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Db3pVVkpQdENiNW9WWkRDVWdjNmtjN3ZrNldkV1VhbEZuTzJMZkhzNlVndGtRWktMVk85djltVUd1aWQzRXhLSVVvVmhUaXlHZUtpLWoxLTZDLVo1cGZv?oc=5" target="_blank">Comparative modelling of foetal exposure to maternal long-acting injectable versus oral daily antipsychotics</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMi1AJBVV95cUxNS2g0N3JsUkgyNEU4SkcxUzk0RlhTY3pPR0xHZmFUODhTVVNiSE0xdUs5UmxUYWFSVFFVRHljSVpGbV9qMEZWT2o1Y2RXUktCUVFJUEhWT1FfSVgzZ3l3NlpxVF9Wb0ExNzJHUlhnVUU5UTd3Q2ktUFZIY3I4UGE5eXBjbXExX0hHM3RCaFZTMU5EUUtubTZhdWdfZHA5Mi1LdmtMQmU3cE1jbFcyUFVHbHo1SmphNzZtUm5TR1F1V3NkZGN0VnRYRnViYzBpV2NLeDN0eWg1YVFvVXdKMFhKRTJucjVSNWN1S2lnOTZ5QWtYd1d0b0hYNUlVTWdTZXVFVDlBb0lfQnFGNjZmeDB0d19tZS1RV29uSUZfbFF6LU1HTEo5RFo1Z1BxNWF5d0dnTnB5RmtsYWNCSGQwTHNuekpLN1NMN0ZDMGJKWk5wYWs1OUtk?oc=5" target="_blank">Aripiprazole Once Monthly in Recent-Onset Schizophrenia</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2Vi03dWk0UWEyWHN0M1lKLUxwY3pTZE55ZVZ2aDlGc3JWd1VrcHJOMDEyZHl6VHBWNFlXMXNqUWRUNkhEakc5bXhZSEtWZTBmOVNCU0d5d3RyQ2VSNVpN?oc=5" target="_blank">Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNMEFwVWNtb0x0UlBDREVjaGNzQ1RvZDh4TjBleGJ5SzlCMFpENkI4dDNkVFEwbDR6VWpzQjZyXzZuVURraEtDTFFHSV9PZzBtWFk2d0F2UUs5M0FESnZXamxUNmphQ3VIbU5Ra3BYaU1xVXN6anRzTFJHRnNCUWxDR3dLbmpUMEpwQ3hDdF8xcG5ULXlKWEd5TFZWTTlmMC1ud0t2RDYxeENxdDN0OTRkT1YxNUV3elNJdzlxaA?oc=5" target="_blank">Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatrist.com</font>
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOWnIwMDlWUGh2eURqNWMxTUpJWFViQlZmakVPZmRFYU0xMVBBaWVZWkZlOTVYYXBHU0dJYVMyckdWeU9HRUZoWnk3RE5ZTElacHd5T0MwaTBNMEpEVlJJaFJOVFF5Z2pSaXliZ0ZzRDNSSjBiMlVzR0pST0xCdGJGMUpBYmdOeS1LNUxTd3lZVC1OUWtzb2Vsd29zdzcxMmpmUW1xNkpZcDhiUnFBaE5qYThfa0xXYmVtbEFxSlV1NkZCdW1wVm1SdjJnRQ?oc=5" target="_blank">Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long | NDT</a>&nbsp;&nbsp;<font color="#6f6f6f">Dove Medical Press</font>
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9YaXpHMkEyU1RFWF93ckFTdGNzcGs5d245N19lX0NYMTZCa0c1LW9ZZlJYWTk0bEJJaWRGdS00WjNZM2IyWUxxZTJBdWY2Z09nN3dsQWFjdE1jV1RKc2NSd051MURUVzdPMkJF?oc=5" target="_blank">Exploring the efficacy and tolerability of two-injection start regimen of long-acting aripiprazole: A descriptive case series analysis</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPaFlrTFlZbk05c0RkU1dSbmd1cGhGSDN5SDk2TEFMeTl6VDJuckFMVWpHZXpDUkFXbG5ZY3cwbHgzdnlSUGt5WTdETGcyUWVvQzNBLVJOWW9HTWZkWHNZWW9abXdsOExKaWZuTmhXRjB5WGFaUkpvM0FsMy03NUpnSkR1TnJ5ZkxDYXJQbldOUmFwQWVDNy1YMGpNTTVuZDZ3SHlVNVBFNEFmU3hNZkVQSFA2bjVoa1RoUk1yMEczX2VxRjZmNTdUVnRB?oc=5" target="_blank">How Long-Acting Injectables May Help People Living with Schizophrenia or Bipolar I Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">MindBodyGreen</font>
<a href="https://news.google.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?oc=5" target="_blank">Otsuka and Lundbeck Published Study Results Showing Aripiprazole 2-Month, Ready-to-Use, Long-Acting Injectable is as Well-Tolerated, and Provides Similar Plasma Levels as Aripiprazole 1-Month for Treatment of Schizophrenia and Bipolar I Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQTzFsUDNGbmt5Zjdkem01U0hWS2hEZ0dnNTc2YkRUZDlxUmJQb1p5UGRjY1UydHFGZ1FER1NCcXUtY2Zab2JFQ0N5am5HaksyR3QtaWlKTG5PUlg2LW5DNkg0UDBiWHJXY1JoSGp5REVwQXFTTlUtcF8tN1VfMy1sVmxLU1hxUi1Ka19xX0dOVHJmcUtGSGY0enZmV3RlNHFmOFktLUlIalpjdUEzT2stRVQzMzNaLXdsdG9hTVpLV0dFX1dhWUpZ?oc=5" target="_blank">Otsuka, Lundbeck get real with CGI in first Abilify Maintena DTC campaign</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPLTNWMVppWFNyV1AwYVYtTnFtY1JlQ2VIOExVRk84UEVUQ19sU0ZDRER0a0hmd25iS2k0V2FZYWJUTmkwd2tYSHdjbFdfNjlHSENTNGRwZEMzWjlGTm44Z2d2aXVySzdQQjQzZmNhUjFPaGhLVXgzYjhocHhESldRR3EzUWtDUkJlbW02bm1oRFVackd1a3RIWGxrdWlhUVdSMEU0eGtCaUVzOFZ1VGZucURDN3FGS2pSMkZIbWVkVi1rVUVXQ3lMaHVnYw?oc=5" target="_blank">Spotlight on once-monthly long-acting injectable aripiprazole and its | NDT</a>&nbsp;&nbsp;<font color="#6f6f6f">Dove Medical Press Ltd</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNOFFJQU83Y0dmM3NUd3cyeDJTbWkydzdwcHlkRjNZUGZSOEtVWUNPZUREVUVjOEstbnJEcGxnMFdCXzluNXoyaUhSTjFTdGViSWJGWmFYR3U0cVJKZ2NqU2xDMXFHUHpxcEtOQ2YyT3hOVFQ5Ym5nUjc4TGlKYmQ2c3hBa1hvLW9nMnVmUEVCWDlpbUUyQXA5cS1kQXNhVHl3WWI1eTJR?oc=5" target="_blank">Novel LAI antipsychotic approved in EU | News</a>&nbsp;&nbsp;<font color="#6f6f6f">European Pharmaceutical Review</font>
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQcGpYZXJXTHJCQ214czZhYnh2am9iNFVfUVBJTWktTzcyOTJfSG0tenRkUUoxU2FHVXZuakMybDRCZ3U5V0l2LU9nZGxLZi1lREhXaGx4TVdDT0F4OS00UnJvX3NLT29JRWt3Umstd3c5bE5uYks5S1RPeUtZbDI5RUd6SmFIN3dDb0lTb0pYTmdZbHdRc2NHcU5HazUwQ05vOVRMREgzUHViZzNPZWdkY01seXN4Zlp2MjE3alVFUWs4cDNybTlYaUdFaw?oc=5" target="_blank">FDA Approves Deltoid Injection Site for Abilify Maintena® (aripiprazole) for extended-release injectable suspension in the Treatment of Schizophrenia</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOYlh3Ung5Zk5uLV9xT0tWRFZDTEJVQnlkNllXcC1BREt0SmZoSnZFMVRQYk8wMVExRTZOXzd4TlhYVTd3ZHgxZ210M3U0YmQ3TU9hM1AwVGM1aVZlTFREMjl0cDFWMEhEeWE0eTFoNF9aZjFzZjRGSmZfZHdQRzZ4N2xlUGhQeEhKN3NjTDN0OUxva3hEelVNMkliSFE3bW52T0ZVakVhRFBVVVdqT2dqZHQwLUhhQQ?oc=5" target="_blank">Otsuka, Lundbeck run CGI Abilify ad in promotional push for long-acting bipolar drug</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPWEpJdm01VkRFUUVZclY2WktVRmRYSEZEa050cUNJQm1tdEtaXzRORE5yUl9xOHNXY2laRmhiM2FxSE5wRmQ5cWcxZTJpZk1ldUFxWEpuYjNWYWxCekdhSjJiX2w4aTdzaHoySDVXWl9vMFBOUldjMXptTWFFRkNBQVFIWGQ0Sk90S1NQSlduNzVxbFVxdmhTNXUxWlc0X3ZGVXEwYW9uVE5yM2pPU1VsejZFU0J6QkRFdHBUQVdtU25lY3pZR2I4?oc=5" target="_blank">FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>